Effectiveness of antiepileptic therapy in patients with PCDH19 mutations
- 1 February 2016
- journal article
- research article
- Published by Elsevier in Seizure: European Journal of Epilepsy
- Vol. 35, 106-110
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- PCDH19-related female-limited epilepsy: Further details regarding early clinical features and therapeutic efficacyEpilepsy Research, 2013
- Identification of SCN1A and PCDH19 Mutations in Chinese Children with Dravet SyndromePLOS ONE, 2012
- Cognitive and behavioral profile in females with epilepsy with PDCH19 mutation: Two novel mutations and review of the literatureEpilepsy & Behavior, 2012
- PCDH19 mutation in Japanese females with epilepsyEpilepsy Research, 2012
- Molecular genetics of Dravet syndromeDevelopmental Medicine & Child Neurology, 2011
- Current therapeutic procedures in Dravet syndromeDevelopmental Medicine & Child Neurology, 2011
- Mutations and deletions in PCDH19 account for various familial or isolated epilepsies in femalesHuman Mutation, 2010
- Protocadherin 19 mutations in girls with infantile-onset epilepsyNeurology, 2010
- Correction: Sporadic Infantile Epileptic Encephalopathy Caused by Mutations in PCDH19 Resembles Dravet Syndrome but Mainly Affects FemalesPLOS Genetics, 2009
- X-linked protocadherin 19 mutations cause female-limited epilepsy and cognitive impairmentNature Genetics, 2008